Literature DB >> 18332828

A basic fibroblast growth factor improves lower extremity wound healing with a porcine-derived skin substitute.

Sadanori Akita1, Kozo Akino, Katsumi Tanaka, Kuniaki Anraku, Akiyoshi Hirano.   

Abstract

BACKGROUND: Although a number of cytokine or growth factor therapies for wound acceleration have been reported, few mentioned the quality of the outcome. The lower extremity is important in esthetics as well as in function, because it is exposed. Recently, a growth factor, namely basic growth factor (bFGF) is widely used for difficult wound healing with a porcine-derived bilayered artificial dermis for better wound closure. Thus, their combination use was tested clinically.
METHODS: Sequential lower extremity reconstruction by an artificial dermis with or without bFGF administration and secondary split-thickness skin grafting was measured for hardness using a durometer, and the moisture parameters assessed such as effective contact coefficient, transepidermal water loss (TEWL), water content and thickness using a moisture meter for at least 6 months after the final procedure and compared with normal skin control.
RESULTS: There was significantly less skin hardness using a durometer in bFGF treatment compared with non-bFGF treatment (16.2 +/- 3.83 vs. 29.2 +/- 4.94, p < 0.01). Effective contact coefficient, TEWL, water content, and thickness in non-bFGF treatment were all significantly greater than those in bFGF treatment, whereas water content and thickness in bFGF treatment were comparable with those of the control.
CONCLUSION: The use of bFGF as artificial dermis for extensive and deeper tissue loss coverage demonstrated better reconstruction quality in terms of hardness using a durometer and the function of the stratum corneum by moisture analysis.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18332828     DOI: 10.1097/TA.0b013e31802c8247

Source DB:  PubMed          Journal:  J Trauma        ISSN: 0022-5282


  11 in total

1.  An exploratory clinical trial for combination wound therapy with a novel medical matrix and fibroblast growth factor in patients with chronic skin ulcers: a study protocol.

Authors:  Naoki Morimoto; Kenichi Yoshimura; Miyuki Niimi; Tatsuya Ito; Harue Tada; Satoshi Teramukai; Toshinori Murayama; Chikako Toyooka; Satoru Takemoto; Katsuya Kawai; Masayuki Yokode; Akira Shimizu; Shigehiko Suzuki
Journal:  Am J Transl Res       Date:  2012-01-05       Impact factor: 4.060

2.  Advancements in the Delivery of Growth Factors and Cytokines for the Treatment of Cutaneous Wound Indications.

Authors:  Caitlin Berry-Kilgour; Jaydee Cabral; Lyn Wise
Journal:  Adv Wound Care (New Rochelle)       Date:  2020-11-25       Impact factor: 4.730

3.  Noncultured autologous adipose-derived stem cells therapy for chronic radiation injury.

Authors:  Sadanori Akita; Kozo Akino; Akiyoshi Hirano; Akira Ohtsuru; Shunichi Yamashita
Journal:  Stem Cells Int       Date:  2010-12-01       Impact factor: 5.443

4.  A rat excised larynx model of vocal fold scar.

Authors:  Nathan V Welham; Douglas W Montequin; Ichiro Tateya; Tomoko Tateya; Seong Hee Choi; Diane M Bless
Journal:  J Speech Lang Hear Res       Date:  2009-08       Impact factor: 2.297

Review 5.  The neck burn scar contracture: a concept of effective treatment.

Authors:  Sadanori Akita; Kenji Hayashida; Satoshi Takaki; Yoshihisa Kawakami; Takuto Oyama; Hiroyuki Ohjimi
Journal:  Burns Trauma       Date:  2017-07-13

Review 6.  The Japanese Experience with Basic Fibroblast Growth Factor in Cutaneous Wound Management and Scar Prevention: A Systematic Review of Clinical and Biological Aspects.

Authors:  Mohamed Abdelhakim; Xunxun Lin; Rei Ogawa
Journal:  Dermatol Ther (Heidelb)       Date:  2020-06-06

Review 7.  Bioaugmentation in the surgical treatment of anterior cruciate ligament injuries: A review of current concepts and emerging techniques.

Authors:  Austin MacFarland Looney; Joseph Daniel Leider; Andrew Ryan Horn; Blake Michael Bodendorfer
Journal:  SAGE Open Med       Date:  2020-05-12

8.  Selection of Artificial Dermis for Shortening Treatment Period: Integra versus Pelnac.

Authors:  Tsutomu Kashimura; Keito Nagasaki; Michio Horigome; Kotoku Yoshida; Kazutaka Soejima
Journal:  Plast Reconstr Surg Glob Open       Date:  2021-06-10

9.  Fibroblast growth factor 2 accelerates the epithelial-mesenchymal transition in keratinocytes during wound healing process.

Authors:  Yuta Koike; Mariko Yozaki; Atsushi Utani; Hiroyuki Murota
Journal:  Sci Rep       Date:  2020-10-29       Impact factor: 4.379

Review 10.  Radiation-induced skin injury: pathogenesis, treatment, and management.

Authors:  Xiaojing Yang; Hanru Ren; Xiaomao Guo; Chaosu Hu; Jie Fu
Journal:  Aging (Albany NY)       Date:  2020-11-16       Impact factor: 5.682

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.